Dr. Saltz, an internationally recognized expert in developing new drug therapies for colorectal cancer, joined the Memorial-Sloan Kettering faculty in 1989.
Leonard B. Saltz has been appointed Chief of the Gastrointestinal Medical Oncology Service. He succeeds David Paul Kelsen, who stepped down in 2011 after 20 years of service to focus on his clinical and research work.
Dr. Saltz is an expert in managing cancers of the colon and rectum, as well as rare tumors of the digestive tract such as carcinoid and pancreatic neuroendocrine tumors. An internationally recognized expert in developing new drug therapies for colorectal cancer, he has developed an integrated translational research program that brings together colleagues in other clinical departments, the Human Oncology and Pathogenesis Program, the Sloan Kettering Institute, and The Rockefeller University.
After receiving his MD degree from Yale University, Dr. Saltz completed residencies and a fellowship at The New York Hospital/Cornell Medical Center. He joined the Memorial Sloan Kettering faculty in 1989, and was appointed co-leader of the Colorectal Disease Management Team in 2001 and Acting Chief of the Gastrointestinal Medical Oncology Service in 2011. He is board certified in internal medicine, medical oncology, and hematology.